TY - JOUR
T1 - Evaluation of a Multifaceted Intervention to Reduce Health Disparities in Hepatitis C Screening
T2 - A Pre-Post Analysis
AU - Jain, Mamta K.
AU - Rich, Nicole E.
AU - Ahn, Chul
AU - Turner, Barbara J.
AU - Sanders, Joanne M.
AU - Adamson, Brian
AU - Quirk, Lisa
AU - Perryman, Patrice
AU - Santini, Noel O.
AU - Singal, Amit G.
N1 - Funding Information:
We are grateful to Christopher Clark from the Office of Research Administration at Parkland Health & Hospital System for his programming and content expertise.
Funding Information:
Received February 18, 2019; accepted March 25, 2019. Additional Supporting Information may be found at onlinelibrary.wiley.com/doi/10.1002/hep.30638/suppinfo. Supported by the Cancer Prevention Research Institute of Texas (PP 150079 to B.J.T.) and Gilead Sciences (to A.G.S.). We acknowledge Gilead’s FOCUS Program, a public health initiative that enables partners to develop and share best practices in routine blood-borne virus (HIV, HCV, hepatitis B) screening, diagnosis, and linkage to care in accordance with screening guidelines promulgated by the US Centers for Disease Control and Prevention, the US Preventive Services Task Force, and state and local public health departments. FOCUS funding supports HIV, HCV, and hepatitis B virus screening and linkage to the first medical appointment after diagnosis. FOCUS partners do not use FOCUS awards for activities beyond linkage to the first medical appointment. © 2019 by the American Association for the Study of Liver Diseases. View this article online at wileyonlinelibrary.com. DOI 10.1002/hep.30638 Potential conflict of interest: Dr. Jain received grants from Gilead, Merck, and Janssen. Dr. Singal consults for and received grants from Instadiagnostics. He advises and received grants from AbbVie and Gilead. He advises Bristol-Myers Squibb.
Publisher Copyright:
© 2019 by the American Association for the Study of Liver Diseases.
PY - 2019/7
Y1 - 2019/7
N2 - Hepatitis C virus (HCV) testing in persons born from 1945 to 1965 has had limited adoption despite guidelines, particularly among racial/ethnic minorities and socioeconomically disadvantaged patients, who have a higher prevalence of disease burden. We examined the effectiveness of a multifaceted intervention to improve HCV screening in a large safety-net health system. We performed a multifaceted intervention that included provider and patient education, an electronic medical record–enabled best practice alert, and increased HCV treatment capacity. We characterized HCV screening completion before and after the intervention. To identify correlates of HCV screening, we performed logistic regression for the preintervention and postintervention groups and used a generalized linear mixed model for patients observed in both preintervention and postintervention time frames. Before the intervention, 10.1% of 48,755 eligible baby boomer patients were screened. After the intervention, 34.6% of the 34,093 eligible baby boomers were screened (P < 0.0001). Prior to the intervention, HCV screening was lower among older baby boomers and providers with large patient panels and higher in high-risk subgroups including those with signs of liver disease (e.g., elevated transaminases, thrombocytopenia), human immunodeficiency virus–positive patients, and homeless patients. Postintervention, we observed increased screening uptake in older baby boomers, providers with larger patient panel size, and patients with more than one prior primary care appointment. Conclusion: Our multifaceted intervention significantly increased HCV screening, particularly among older patients, those engaged in primary care, and providers with large patient panels.
AB - Hepatitis C virus (HCV) testing in persons born from 1945 to 1965 has had limited adoption despite guidelines, particularly among racial/ethnic minorities and socioeconomically disadvantaged patients, who have a higher prevalence of disease burden. We examined the effectiveness of a multifaceted intervention to improve HCV screening in a large safety-net health system. We performed a multifaceted intervention that included provider and patient education, an electronic medical record–enabled best practice alert, and increased HCV treatment capacity. We characterized HCV screening completion before and after the intervention. To identify correlates of HCV screening, we performed logistic regression for the preintervention and postintervention groups and used a generalized linear mixed model for patients observed in both preintervention and postintervention time frames. Before the intervention, 10.1% of 48,755 eligible baby boomer patients were screened. After the intervention, 34.6% of the 34,093 eligible baby boomers were screened (P < 0.0001). Prior to the intervention, HCV screening was lower among older baby boomers and providers with large patient panels and higher in high-risk subgroups including those with signs of liver disease (e.g., elevated transaminases, thrombocytopenia), human immunodeficiency virus–positive patients, and homeless patients. Postintervention, we observed increased screening uptake in older baby boomers, providers with larger patient panel size, and patients with more than one prior primary care appointment. Conclusion: Our multifaceted intervention significantly increased HCV screening, particularly among older patients, those engaged in primary care, and providers with large patient panels.
UR - http://www.scopus.com/inward/record.url?scp=85066470707&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85066470707&partnerID=8YFLogxK
U2 - 10.1002/hep.30638
DO - 10.1002/hep.30638
M3 - Article
C2 - 30950085
AN - SCOPUS:85066470707
SN - 0270-9139
VL - 70
SP - 40
EP - 50
JO - Hepatology
JF - Hepatology
IS - 1
ER -